Oorsprong van het eerstegraads netwerk van Julia Hillebrand
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
EVER Pharma Holding GmbH
 EVER Pharma Holding GmbH Pharmaceuticals: MajorHealth Technology EVER Pharma Holding GmbH engages in the research in as well as development, production, and distribution of pharmaceutical products in the areas of neurology, intensive medicine, anesthesiology, and oncology. Its business activities also include the management and strategic development of shareholdings. The company was founded on August 25, 2001 and is headquartered in Salzburg, Austria.
1
| Private Company | Pharmaceuticals: Major | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Julia Hillebrand via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
EBEWE Pharma Ges.m.b.H. Nfg.KG
 EBEWE Pharma Ges.m.b.H. Nfg.KG Pharmaceuticals: MajorHealth Technology EBEWE Pharma Ges.m.b.H. Nfg.KG engages in the development and manufacture of injectable pharmaceutical specialties. The firm offers therapy solutions for colon, lung, breast, and prostate cancer. It also specializes in drug and pharmaceutical development, as well as preclinical studies. The company was founded in 1934 and is headquartered in Unterach am Attersee, Austria. | Pharmaceuticals: Major | Chief Executive Officer | |
EVER Neuro Pharma GmbH
 EVER Neuro Pharma GmbH Pharmaceuticals: MajorHealth Technology Part of EVER Pharma Holding GmbH, EVER Neuro Pharma GmbH is an Austrian company that engages in research, development, production and commercialization of pharmaceutical products. The company is based in Unterach, Austria. The company was founded in 1934. The CEO is Georges Kahwati. | Pharmaceuticals: Major | Chief Executive Officer | |
UroMems SAS
 UroMems SAS Medical SpecialtiesHealth Technology UroMems SASdesigns and develops implantable medical devices. Its product is an active implantable medical device which compensates for sphincter insufficiency with the help of a MyoElectroMechanical System. The company was founded by Hamid Lamraoui in 2011 and is headquartered in Grenoble, France. | Medical Specialties | Director/Board Member |
Statistieken
Internationaal
| Oostenrijk | 3 |
| Frankrijk | 2 |
Sectoraal
| Health Technology | 4 |
Operationeel
| Chief Executive Officer | 3 |
| Director/Board Member | 1 |
Sterkste connecties
| Insiders | |
|---|---|
| Friedrich Hillebrand | 4 |
- Beurs
- Insiders
- Julia Hillebrand
- Bedrijfsconnecties
